Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Features of Childhood Acute Myeloid Leukemia in Iran: A Report From Double Center Study Pubmed



Mehrvar A1 ; Rahiminejad MS2 ; Asl AAH3 ; Tashvighi M4 ; Faranoush M5 ; Alebouyeh M3 ; Kuchakzadeh L2 ; Ramyar A2 ; Sabery Nejad J6 ; Mehrvar N7
Authors

Source: Acta Medica Iranica Published:2015


Abstract

Acute Myeloblastic Leukemia is one of the important malignancies in children. For better managing the prognosis of this disease, there should be enough information about common features of this malignancy. The aim of this study was to evaluate these common features in children with Acute Myeloblastic Leukemia. A total of 104 eligible children less than 15-year-old have been referred from 2007-2011 to two referral centers for childhood malignancies. Basic epidemiological information recorded in checklists for each individual. Analyzes have been done by SPSS version 22. Out of patients, 57 cases were males (54.8%). The male/female ratio was 1.2. The mean age of patients was 6.5 ± 4.3 years. The majority subtypes of patients were M3, M4, non-M3, and M2, respectively. The common molecular abnormalities were t (15;17) and inv (16). Of patients, 19.2% had an early relapse. The mean age of relapse in patients was 6.7 ± 3.9 years. Sixty patients (57.7%) were alive, and 44 cases (42.3%) died during or after therapy. The three years overall survival rate of patients was 42% in this study. According to our data, AML has the same frequency as compared with data from developing countries. But different epidemiological characteristic was a lower rate of three years overall survival in patients. These data may serve the health authorities for more effective environmental and preventive measurements, purposeful allocation of resources for facilitating upto-date diagnostic and treatment modalities, psychological support programs for respective family members and educational purposes. © 2015 Tehran University of Medical Sciences. All rights reserved.
Other Related Docs
6. Imatinib Efficacy, Safety and Resistance in Iranian Patients With Chronic Myeloid Leukemia: A Review of Literature, International Journal of Hematology-Oncology and Stem Cell Research (2021)
10. Association of G15631t, Cyp2b6 Gene Polymorphism With Susceptibility to Acute Myeloid Leukemia, Journal of Zanjan University of Medical Sciences and Health Services (2016)
15. Epidemiology and Trend of Incidence of the Leukemia in Iran, Journal of Isfahan Medical School (2016)
20. Ocular Manifestations of Newly Diagnosed Acute Leukemia Patients, Journal of Current Ophthalmology (2022)